BioTime Creates Asian Subsidiary
The U.S. company BioTime Inc. and the the Hong Kong company Nashan Memorial Medical Institute today announced the collabortive formation…
View Article
Blog Articles
Explore our articles
Fat-Derived Adult Stem Cells Targeted for Heart Disease Therapy
Once again, adult stem cells derived from adipose (fat) tissue are in the news for the therapeutic promise that they…
View ArticleRace Horse Returns to Racing After Adult Stem Cell Therapy
Lava Man, the 8-year-old gelding who retired from racing last year, is now returning to racing and indefinitely postponing his…
View ArticleOnline Cord Blood Education Program Designed to Improve Public Awareness
In a growing effort to increase public awareness of the importance of storing adult stem cells that are derived from…
View ArticleStem Cell Awareness Day Events Planned in California
Events throughout California are planned in honor of Stem Cell Awareness Day today, with particularly notable activity scheduled at UC-Merced.…
View ArticleAdult Stem Cells Used in Clinical Trial for Heart Failure
The Florida-based company Bioheart announced today results from Part 1 of its FDA-approved Phase II/III clinical trial in which its…
View ArticleStemgent Sponsors Harvard Seminar Series
The biotech company Stemgent announced today that it has pledged a financial gift to the Harvard Stem Cell Institute (HSCI)…
View ArticleEastern European Stem Cell Symposium Hosts International Speakers
The International Summer School for Stem Cells and Regenerative Medicine in Piran, Slovenia has just finished hosting an international panel…
View ArticleU.S. and Jordanian Stem Cell Companies Sign Agreement
Stemedica Cell Technologies announced today the signing of an agreement with the Jordanian Stem Cell Company. The five-year, multi-million-dollar deal…
View Article